Status:
UNKNOWN
Contribution of Virtual Reality and Modelling in Falling Risk Assessment in Elderly and Parkinson's Disease Patients
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
OHS - Office d'Hygiène Sociale
ONPA - Office Nancéien des Personnes Agées
Conditions:
Aging Disorder
Parkinson Disease
Eligibility:
All Genders
65-80 years
Phase:
NA
Brief Summary
The process of ageing affects at the same time the sensory, cognitive and driving functions. Furthermore, ageing is often accompanied by pathologies increasing the effects of the senescence. An ageing...
Eligibility Criteria
Inclusion
- Non-faller elderly
- Male and female
- Age between 65 and 80 years old
- Autonomous
- Reporting no fall in the last 12 months
- Fallers elderly
- Male and female
- Age between 65 and 80 years old
- Autonomous
- Reporting at least 1 fall in the last 12 months
- Non-faller Patients with Parkinson's disease
- Male and female
- Age between 65 and 80 years old
- Autonomous
- Reporting no fall in the last 12 months
- Dopa-sensitive
- In ON period of treatment of Parkinson's disease
Exclusion
- Hearing loss preventing understanding of the instructions and listening to the sound message
- Visual acuity not compatible with the test procedure in virtual reality
- Inability to move without assistance
- Not understanding written and oral French, illiteracy, dementia
- Treatment including psychotropic drugs
- Person in emergency situation,
- Major person subject to a legal protection measure (guardianship, curator, safeguard of justice),
- Major person unable to express his consent,
- Hospitalized person,
- Person deprived of liberty by a judicial or administrative decision, the persons being the object of psychiatric care by virtue of articles L. 3212-1 and L. 3213-1 of the french Code of Public Health,
- Person likely, in the opinion of the investigator, not to be cooperating or respectful of the obligations inherent to participation in the study
- Person with a predisposition to epilepsy
Key Trial Info
Start Date :
April 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT03848897
Start Date
April 30 2019
End Date
June 30 2022
Last Update
April 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Nancy
Vandœuvre-lès-Nancy, France, 54500